After-Hours Stock Movers: Adobe Falls on Lower Guidance; U.S. Steel Rises on Higher Guidance

StreetInsider2022-06-17

After-Hours Stock Movers:Rhythm Pharmaceuticals 14% LOWER; Confirmed the FDA has approved the Company’s supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide), a melanocortin-4 ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

NP_YT
2022-06-18
NP_YT
Ok
RW5
2022-06-17
RW5
O
小虎一飞冲天
2022-06-17
小虎一飞冲天
Like pls
Pepermintpat
2022-06-17
Pepermintpat
Like
Mkoh
2022-06-17
Mkoh
Horrific plunge
Jenyii
2022-06-17
Jenyii
Ok

Leave a comment

271

671

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2244607159?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-06-17 07:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2244607159","market":"us","top_or_hot":-1,"title":"After-Hours Stock Movers: Adobe Falls on Lower Guidance; U.S. Steel Rises on Higher Guidance","media":"StreetInsider","content":"<div>\n<p>After-Hours Stock Movers:Rhythm Pharmaceuticals 14% LOWER; Confirmed the FDA has approved the Company’s supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide), a melanocortin-4 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=20225684\">Source Link</a>\n\n</div>\n","source":"highlight_streetinsider","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Adobe Falls on Lower Guidance; U.S. Steel Rises on Higher Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Adobe Falls on Lower Guidance; U.S. Steel Rises on Higher Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-06-17 07:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=20225684><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Rhythm Pharmaceuticals 14% LOWER; Confirmed the FDA has approved the Company’s supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide), a melanocortin-4 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=20225684\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4528","symbol_name":"SaaS概念","start_time":0,"source_url":"https://www.streetinsider.com/dr/news.php?id=20225684","article_id":"2244607159","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2244607159","pubTimestamp":1655422063,"sourceInfo":{"source_id":"highlight_streetinsider","name":"StreetInsider"},"weMediaInfo":null,"summary":"After-Hours Stock Movers:Rhythm Pharmaceuticals 14% LOWER; Confirmed the FDA has approved the Compan","collect":0,"end_time":0,"defaultTopTitle":"streetinsider.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4528":"SaaS概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4023":"应用软件","BK4516":"特朗普概念","BK4581":"高盛持仓","BK4566":"资本集团","BK4554":"元宇宙及AR概念","RYTM":"Rhythm Pharmaceuticals Inc.","BK4527":"明星科技股","BK4520":"美国基建股","BK4534":"瑞士信贷持仓","X":"美国钢铁","ADBE":"Adobe","BK4567":"ESG概念"},"translate_title":"盘后股票市场：Adobe跌至较低指引；美国钢铁在更高的指导下上涨","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ADBE":1,"X":1,"RYTM":0.9},"content_text":"After-Hours Stock Movers:Rhythm Pharmaceuticals 14% LOWER; Confirmed the FDA has approved the Company’s supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide), a melanocortin-4 receptor (MC4R) agonist, for patients with Bardet-Biedl syndrome (BBS). Also, the FDA issued a complete response letter for the sNDA for setmelanotide in Alström syndrome.Global Cord Blood Corporation 11% HIGHER; announce that Cellenkos, Inc. recently announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application to initiate a Phase 1b, open-label study of CK0804 as an add on therapy to ruxolitinib in patients with myelofibrosis who experience a suboptimal response to ruxolitinib.United States Steel Corporation 6% HIGHER; adjusted EBITDA expected to be approximately $1.6 billion, representing a new all-time best Q2 performance. Adjusted EPS is expected to range from $3.83 to $3.88, versus the consensus of $3.20.Adobe Systems 4% LOWER; reported Q2 EPS of $3.35, $0.04 better than the analyst estimate of $3.31. Revenue for the quarter came in at $4.39 billion versus the consensus estimate of $4.34 billion. Adobe Systems sees Q3 2022 EPS of $3.33, versus the consensus of $3.40. Adobe Systems sees Q3 2022 revenue of $4.43 billion, versus the consensus of $4.51 billion. Adobe Systems sees FY2022 EPS of $13.50, versus the consensus of $13.66. Adobe Systems sees FY2022 revenue of $17.65 billion, versus the consensus of $17.85 billionLAVA Therapeutics N.V. 3% HIGHER; hosted a clinical update call focused on encouraging initial Phase 1/2a clinical data for LAVA-051 in patients with chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) patients following poster presentations at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting held June 3-7, 2022, and the European Hematology Association (EHA) 2022 Congress, held June 9-12, 2022.Targa Resources Corp. 3% HIGHER; Agreed to acquire Lucid Energy Delaware, LLC from Riverstone Holdings LLC and Goldman Sachs Asset Management for $3.55 billion in cash.Bausch Health Companies Inc. (NYSE: BHC) 2% HIGHER; Suspending IPO of Solta Medical.Oasis Petroleum Inc. (NASDAQ: OAS) 1% HIGHER; announced today that its Board of Directors has, subject to certain conditions, declared a special dividend of $15.00 per share of Oasis common stock in connection with the Whiting Petroleum merger.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9057639854,"gmtCreate":1655509931978,"gmtModify":1676535652324,"author":{"id":"3572043809285615","authorId":"3572043809285615","name":"NP_YT","avatar":"https://static.itradeup.com/news/fad9f70abb174e3e09e4caf3f9c0c13a","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3572043809285615","authorIdStr":"3572043809285615"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9057639854","repostId":2244607159,"repostType":4,"repost":{"id":"2244607159","pubTimestamp":1655422063,"share":"https://ttm.financial/m/news/2244607159?lang=&edition=fundamental","pubTime":"2022-06-17 07:27","market":"us","language":"en","title":"After-Hours Stock Movers: Adobe Falls on Lower Guidance; U.S. Steel Rises on Higher Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2244607159","media":"StreetInsider","summary":"After-Hours Stock Movers:Rhythm Pharmaceuticals 14% LOWER; Confirmed the FDA has approved the Compan","content":"<html><head></head><body><p><b>After-Hours Stock Movers:</b></p><p><a href=\"https://laohu8.com/S/RYTM\">Rhythm Pharmaceuticals</a> 14% LOWER; Confirmed the FDA has approved the Company’s supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide), a melanocortin-4 receptor (MC4R) agonist, for patients with Bardet-Biedl syndrome (BBS). Also, the FDA issued a complete response letter for the sNDA for setmelanotide in Alström syndrome.</p><p><a href=\"https://laohu8.com/S/CO\">Global Cord Blood Corporation</a> 11% HIGHER; announce that Cellenkos, Inc. recently announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application to initiate a Phase 1b, open-label study of CK0804 as an add on therapy to ruxolitinib in patients with myelofibrosis who experience a suboptimal response to ruxolitinib.</p><p><a href=\"https://laohu8.com/S/X\">United States Steel Corporation</a> 6% HIGHER; adjusted EBITDA expected to be approximately $1.6 billion, representing a new all-time best Q2 performance. Adjusted EPS is expected to range from $3.83 to $3.88, versus the consensus of $3.20.</p><p><a href=\"https://laohu8.com/S/ADBE\">Adobe Systems</a> 4% LOWER; reported Q2 EPS of $3.35, $0.04 better than the analyst estimate of $3.31. Revenue for the quarter came in at $4.39 billion versus the consensus estimate of $4.34 billion. Adobe Systems sees Q3 2022 EPS of $3.33, versus the consensus of $3.40. Adobe Systems sees Q3 2022 revenue of $4.43 billion, versus the consensus of $4.51 billion. Adobe Systems sees FY2022 EPS of $13.50, versus the consensus of $13.66. Adobe Systems sees FY2022 revenue of $17.65 billion, versus the consensus of $17.85 billion</p><p><a href=\"https://laohu8.com/S/LVTX\">LAVA Therapeutics N.V.</a> 3% HIGHER; hosted a clinical update call focused on encouraging initial Phase 1/2a clinical data for LAVA-051 in patients with chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) patients following poster presentations at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting held June 3-7, 2022, and the European Hematology Association (EHA) 2022 Congress, held June 9-12, 2022.</p><p><a href=\"https://laohu8.com/S/TRGP\">Targa Resources Corp</a>. 3% HIGHER; Agreed to acquire Lucid Energy Delaware, LLC from Riverstone Holdings LLC and Goldman Sachs Asset Management for $3.55 billion in cash.</p><p><a href=\"https://laohu8.com/S/BHC\">Bausch Health Companies Inc</a>. (NYSE: BHC) 2% HIGHER; Suspending IPO of Solta Medical.</p><p><a href=\"https://laohu8.com/S/OAS\">Oasis Petroleum</a> Inc. (NASDAQ: OAS) 1% HIGHER; announced today that its Board of Directors has, subject to certain conditions, declared a special dividend of $15.00 per share of Oasis common stock in connection with the Whiting Petroleum merger.</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Adobe Falls on Lower Guidance; U.S. Steel Rises on Higher Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Adobe Falls on Lower Guidance; U.S. Steel Rises on Higher Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-06-17 07:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=20225684><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Rhythm Pharmaceuticals 14% LOWER; Confirmed the FDA has approved the Company’s supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide), a melanocortin-4 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=20225684\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4520":"美国基建股","RYTM":"Rhythm Pharmaceuticals Inc.","BK4567":"ESG概念","BK4534":"瑞士信贷持仓","BK4527":"明星科技股","X":"美国钢铁","BK4566":"资本集团","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4554":"元宇宙及AR概念","BK4528":"SaaS概念","BK4516":"特朗普概念","BK4023":"应用软件","ADBE":"Adobe"},"source_url":"https://www.streetinsider.com/dr/news.php?id=20225684","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2244607159","content_text":"After-Hours Stock Movers:Rhythm Pharmaceuticals 14% LOWER; Confirmed the FDA has approved the Company’s supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide), a melanocortin-4 receptor (MC4R) agonist, for patients with Bardet-Biedl syndrome (BBS). Also, the FDA issued a complete response letter for the sNDA for setmelanotide in Alström syndrome.Global Cord Blood Corporation 11% HIGHER; announce that Cellenkos, Inc. recently announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application to initiate a Phase 1b, open-label study of CK0804 as an add on therapy to ruxolitinib in patients with myelofibrosis who experience a suboptimal response to ruxolitinib.United States Steel Corporation 6% HIGHER; adjusted EBITDA expected to be approximately $1.6 billion, representing a new all-time best Q2 performance. Adjusted EPS is expected to range from $3.83 to $3.88, versus the consensus of $3.20.Adobe Systems 4% LOWER; reported Q2 EPS of $3.35, $0.04 better than the analyst estimate of $3.31. Revenue for the quarter came in at $4.39 billion versus the consensus estimate of $4.34 billion. Adobe Systems sees Q3 2022 EPS of $3.33, versus the consensus of $3.40. Adobe Systems sees Q3 2022 revenue of $4.43 billion, versus the consensus of $4.51 billion. Adobe Systems sees FY2022 EPS of $13.50, versus the consensus of $13.66. Adobe Systems sees FY2022 revenue of $17.65 billion, versus the consensus of $17.85 billionLAVA Therapeutics N.V. 3% HIGHER; hosted a clinical update call focused on encouraging initial Phase 1/2a clinical data for LAVA-051 in patients with chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) patients following poster presentations at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting held June 3-7, 2022, and the European Hematology Association (EHA) 2022 Congress, held June 9-12, 2022.Targa Resources Corp. 3% HIGHER; Agreed to acquire Lucid Energy Delaware, LLC from Riverstone Holdings LLC and Goldman Sachs Asset Management for $3.55 billion in cash.Bausch Health Companies Inc. (NYSE: BHC) 2% HIGHER; Suspending IPO of Solta Medical.Oasis Petroleum Inc. (NASDAQ: OAS) 1% HIGHER; announced today that its Board of Directors has, subject to certain conditions, declared a special dividend of $15.00 per share of Oasis common stock in connection with the Whiting Petroleum merger.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9057014306,"gmtCreate":1655435484705,"gmtModify":1676535639482,"author":{"id":"3582440300426753","authorId":"3582440300426753","name":"RW5","avatar":"https://static.tigerbbs.com/1892f1a4f1e18bdabb9f243266c5c6b3","vip":1,"hat":"https://static.tigerbbs.com/1c1eed764d9c7ff83dc093fbb9a96bc2","crmLevel":2,"crmLevelSwitch":0,"idStr":"3582440300426753","authorIdStr":"3582440300426753"},"htmlText":"O","listText":"O","text":"O","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9057014306","repostId":2244607159,"repostType":4,"repost":{"id":"2244607159","pubTimestamp":1655422063,"share":"https://ttm.financial/m/news/2244607159?lang=&edition=fundamental","pubTime":"2022-06-17 07:27","market":"us","language":"en","title":"After-Hours Stock Movers: Adobe Falls on Lower Guidance; U.S. Steel Rises on Higher Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2244607159","media":"StreetInsider","summary":"After-Hours Stock Movers:Rhythm Pharmaceuticals 14% LOWER; Confirmed the FDA has approved the Compan","content":"<html><head></head><body><p><b>After-Hours Stock Movers:</b></p><p><a href=\"https://laohu8.com/S/RYTM\">Rhythm Pharmaceuticals</a> 14% LOWER; Confirmed the FDA has approved the Company’s supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide), a melanocortin-4 receptor (MC4R) agonist, for patients with Bardet-Biedl syndrome (BBS). Also, the FDA issued a complete response letter for the sNDA for setmelanotide in Alström syndrome.</p><p><a href=\"https://laohu8.com/S/CO\">Global Cord Blood Corporation</a> 11% HIGHER; announce that Cellenkos, Inc. recently announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application to initiate a Phase 1b, open-label study of CK0804 as an add on therapy to ruxolitinib in patients with myelofibrosis who experience a suboptimal response to ruxolitinib.</p><p><a href=\"https://laohu8.com/S/X\">United States Steel Corporation</a> 6% HIGHER; adjusted EBITDA expected to be approximately $1.6 billion, representing a new all-time best Q2 performance. Adjusted EPS is expected to range from $3.83 to $3.88, versus the consensus of $3.20.</p><p><a href=\"https://laohu8.com/S/ADBE\">Adobe Systems</a> 4% LOWER; reported Q2 EPS of $3.35, $0.04 better than the analyst estimate of $3.31. Revenue for the quarter came in at $4.39 billion versus the consensus estimate of $4.34 billion. Adobe Systems sees Q3 2022 EPS of $3.33, versus the consensus of $3.40. Adobe Systems sees Q3 2022 revenue of $4.43 billion, versus the consensus of $4.51 billion. Adobe Systems sees FY2022 EPS of $13.50, versus the consensus of $13.66. Adobe Systems sees FY2022 revenue of $17.65 billion, versus the consensus of $17.85 billion</p><p><a href=\"https://laohu8.com/S/LVTX\">LAVA Therapeutics N.V.</a> 3% HIGHER; hosted a clinical update call focused on encouraging initial Phase 1/2a clinical data for LAVA-051 in patients with chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) patients following poster presentations at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting held June 3-7, 2022, and the European Hematology Association (EHA) 2022 Congress, held June 9-12, 2022.</p><p><a href=\"https://laohu8.com/S/TRGP\">Targa Resources Corp</a>. 3% HIGHER; Agreed to acquire Lucid Energy Delaware, LLC from Riverstone Holdings LLC and Goldman Sachs Asset Management for $3.55 billion in cash.</p><p><a href=\"https://laohu8.com/S/BHC\">Bausch Health Companies Inc</a>. (NYSE: BHC) 2% HIGHER; Suspending IPO of Solta Medical.</p><p><a href=\"https://laohu8.com/S/OAS\">Oasis Petroleum</a> Inc. (NASDAQ: OAS) 1% HIGHER; announced today that its Board of Directors has, subject to certain conditions, declared a special dividend of $15.00 per share of Oasis common stock in connection with the Whiting Petroleum merger.</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Adobe Falls on Lower Guidance; U.S. Steel Rises on Higher Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Adobe Falls on Lower Guidance; U.S. Steel Rises on Higher Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-06-17 07:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=20225684><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Rhythm Pharmaceuticals 14% LOWER; Confirmed the FDA has approved the Company’s supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide), a melanocortin-4 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=20225684\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4520":"美国基建股","RYTM":"Rhythm Pharmaceuticals Inc.","BK4567":"ESG概念","BK4534":"瑞士信贷持仓","BK4527":"明星科技股","X":"美国钢铁","BK4566":"资本集团","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4554":"元宇宙及AR概念","BK4528":"SaaS概念","BK4516":"特朗普概念","BK4023":"应用软件","ADBE":"Adobe"},"source_url":"https://www.streetinsider.com/dr/news.php?id=20225684","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2244607159","content_text":"After-Hours Stock Movers:Rhythm Pharmaceuticals 14% LOWER; Confirmed the FDA has approved the Company’s supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide), a melanocortin-4 receptor (MC4R) agonist, for patients with Bardet-Biedl syndrome (BBS). Also, the FDA issued a complete response letter for the sNDA for setmelanotide in Alström syndrome.Global Cord Blood Corporation 11% HIGHER; announce that Cellenkos, Inc. recently announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application to initiate a Phase 1b, open-label study of CK0804 as an add on therapy to ruxolitinib in patients with myelofibrosis who experience a suboptimal response to ruxolitinib.United States Steel Corporation 6% HIGHER; adjusted EBITDA expected to be approximately $1.6 billion, representing a new all-time best Q2 performance. Adjusted EPS is expected to range from $3.83 to $3.88, versus the consensus of $3.20.Adobe Systems 4% LOWER; reported Q2 EPS of $3.35, $0.04 better than the analyst estimate of $3.31. Revenue for the quarter came in at $4.39 billion versus the consensus estimate of $4.34 billion. Adobe Systems sees Q3 2022 EPS of $3.33, versus the consensus of $3.40. Adobe Systems sees Q3 2022 revenue of $4.43 billion, versus the consensus of $4.51 billion. Adobe Systems sees FY2022 EPS of $13.50, versus the consensus of $13.66. Adobe Systems sees FY2022 revenue of $17.65 billion, versus the consensus of $17.85 billionLAVA Therapeutics N.V. 3% HIGHER; hosted a clinical update call focused on encouraging initial Phase 1/2a clinical data for LAVA-051 in patients with chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) patients following poster presentations at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting held June 3-7, 2022, and the European Hematology Association (EHA) 2022 Congress, held June 9-12, 2022.Targa Resources Corp. 3% HIGHER; Agreed to acquire Lucid Energy Delaware, LLC from Riverstone Holdings LLC and Goldman Sachs Asset Management for $3.55 billion in cash.Bausch Health Companies Inc. (NYSE: BHC) 2% HIGHER; Suspending IPO of Solta Medical.Oasis Petroleum Inc. (NASDAQ: OAS) 1% HIGHER; announced today that its Board of Directors has, subject to certain conditions, declared a special dividend of $15.00 per share of Oasis common stock in connection with the Whiting Petroleum merger.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9057019773,"gmtCreate":1655434688692,"gmtModify":1676535639315,"author":{"id":"3582098623642517","authorId":"3582098623642517","name":"小虎一飞冲天","avatar":"https://static.tigerbbs.com/1a55a61195830e019abf5d3cc69681b9","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3582098623642517","authorIdStr":"3582098623642517"},"htmlText":"Like pls&nbsp;","listText":"Like pls&nbsp;","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9057019773","repostId":2244607159,"repostType":4,"repost":{"id":"2244607159","pubTimestamp":1655422063,"share":"https://ttm.financial/m/news/2244607159?lang=&edition=fundamental","pubTime":"2022-06-17 07:27","market":"us","language":"en","title":"After-Hours Stock Movers: Adobe Falls on Lower Guidance; U.S. Steel Rises on Higher Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2244607159","media":"StreetInsider","summary":"After-Hours Stock Movers:Rhythm Pharmaceuticals 14% LOWER; Confirmed the FDA has approved the Compan","content":"<html><head></head><body><p><b>After-Hours Stock Movers:</b></p><p><a href=\"https://laohu8.com/S/RYTM\">Rhythm Pharmaceuticals</a> 14% LOWER; Confirmed the FDA has approved the Company’s supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide), a melanocortin-4 receptor (MC4R) agonist, for patients with Bardet-Biedl syndrome (BBS). Also, the FDA issued a complete response letter for the sNDA for setmelanotide in Alström syndrome.</p><p><a href=\"https://laohu8.com/S/CO\">Global Cord Blood Corporation</a> 11% HIGHER; announce that Cellenkos, Inc. recently announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application to initiate a Phase 1b, open-label study of CK0804 as an add on therapy to ruxolitinib in patients with myelofibrosis who experience a suboptimal response to ruxolitinib.</p><p><a href=\"https://laohu8.com/S/X\">United States Steel Corporation</a> 6% HIGHER; adjusted EBITDA expected to be approximately $1.6 billion, representing a new all-time best Q2 performance. Adjusted EPS is expected to range from $3.83 to $3.88, versus the consensus of $3.20.</p><p><a href=\"https://laohu8.com/S/ADBE\">Adobe Systems</a> 4% LOWER; reported Q2 EPS of $3.35, $0.04 better than the analyst estimate of $3.31. Revenue for the quarter came in at $4.39 billion versus the consensus estimate of $4.34 billion. Adobe Systems sees Q3 2022 EPS of $3.33, versus the consensus of $3.40. Adobe Systems sees Q3 2022 revenue of $4.43 billion, versus the consensus of $4.51 billion. Adobe Systems sees FY2022 EPS of $13.50, versus the consensus of $13.66. Adobe Systems sees FY2022 revenue of $17.65 billion, versus the consensus of $17.85 billion</p><p><a href=\"https://laohu8.com/S/LVTX\">LAVA Therapeutics N.V.</a> 3% HIGHER; hosted a clinical update call focused on encouraging initial Phase 1/2a clinical data for LAVA-051 in patients with chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) patients following poster presentations at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting held June 3-7, 2022, and the European Hematology Association (EHA) 2022 Congress, held June 9-12, 2022.</p><p><a href=\"https://laohu8.com/S/TRGP\">Targa Resources Corp</a>. 3% HIGHER; Agreed to acquire Lucid Energy Delaware, LLC from Riverstone Holdings LLC and Goldman Sachs Asset Management for $3.55 billion in cash.</p><p><a href=\"https://laohu8.com/S/BHC\">Bausch Health Companies Inc</a>. (NYSE: BHC) 2% HIGHER; Suspending IPO of Solta Medical.</p><p><a href=\"https://laohu8.com/S/OAS\">Oasis Petroleum</a> Inc. (NASDAQ: OAS) 1% HIGHER; announced today that its Board of Directors has, subject to certain conditions, declared a special dividend of $15.00 per share of Oasis common stock in connection with the Whiting Petroleum merger.</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Adobe Falls on Lower Guidance; U.S. Steel Rises on Higher Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Adobe Falls on Lower Guidance; U.S. Steel Rises on Higher Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-06-17 07:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=20225684><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Rhythm Pharmaceuticals 14% LOWER; Confirmed the FDA has approved the Company’s supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide), a melanocortin-4 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=20225684\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4520":"美国基建股","RYTM":"Rhythm Pharmaceuticals Inc.","BK4567":"ESG概念","BK4534":"瑞士信贷持仓","BK4527":"明星科技股","X":"美国钢铁","BK4566":"资本集团","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4554":"元宇宙及AR概念","BK4528":"SaaS概念","BK4516":"特朗普概念","BK4023":"应用软件","ADBE":"Adobe"},"source_url":"https://www.streetinsider.com/dr/news.php?id=20225684","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2244607159","content_text":"After-Hours Stock Movers:Rhythm Pharmaceuticals 14% LOWER; Confirmed the FDA has approved the Company’s supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide), a melanocortin-4 receptor (MC4R) agonist, for patients with Bardet-Biedl syndrome (BBS). Also, the FDA issued a complete response letter for the sNDA for setmelanotide in Alström syndrome.Global Cord Blood Corporation 11% HIGHER; announce that Cellenkos, Inc. recently announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application to initiate a Phase 1b, open-label study of CK0804 as an add on therapy to ruxolitinib in patients with myelofibrosis who experience a suboptimal response to ruxolitinib.United States Steel Corporation 6% HIGHER; adjusted EBITDA expected to be approximately $1.6 billion, representing a new all-time best Q2 performance. Adjusted EPS is expected to range from $3.83 to $3.88, versus the consensus of $3.20.Adobe Systems 4% LOWER; reported Q2 EPS of $3.35, $0.04 better than the analyst estimate of $3.31. Revenue for the quarter came in at $4.39 billion versus the consensus estimate of $4.34 billion. Adobe Systems sees Q3 2022 EPS of $3.33, versus the consensus of $3.40. Adobe Systems sees Q3 2022 revenue of $4.43 billion, versus the consensus of $4.51 billion. Adobe Systems sees FY2022 EPS of $13.50, versus the consensus of $13.66. Adobe Systems sees FY2022 revenue of $17.65 billion, versus the consensus of $17.85 billionLAVA Therapeutics N.V. 3% HIGHER; hosted a clinical update call focused on encouraging initial Phase 1/2a clinical data for LAVA-051 in patients with chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) patients following poster presentations at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting held June 3-7, 2022, and the European Hematology Association (EHA) 2022 Congress, held June 9-12, 2022.Targa Resources Corp. 3% HIGHER; Agreed to acquire Lucid Energy Delaware, LLC from Riverstone Holdings LLC and Goldman Sachs Asset Management for $3.55 billion in cash.Bausch Health Companies Inc. (NYSE: BHC) 2% HIGHER; Suspending IPO of Solta Medical.Oasis Petroleum Inc. (NASDAQ: OAS) 1% HIGHER; announced today that its Board of Directors has, subject to certain conditions, declared a special dividend of $15.00 per share of Oasis common stock in connection with the Whiting Petroleum merger.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9057001920,"gmtCreate":1655431434860,"gmtModify":1676535638622,"author":{"id":"4109504542406510","authorId":"4109504542406510","name":"Pepermintpat","avatar":"https://community-static.tradeup.com/news/0804feddbf156f8e808003b7ca831628","vip":1,"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":3,"crmLevelSwitch":1,"idStr":"4109504542406510","authorIdStr":"4109504542406510"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9057001920","repostId":2244607159,"repostType":4,"repost":{"id":"2244607159","pubTimestamp":1655422063,"share":"https://ttm.financial/m/news/2244607159?lang=&edition=fundamental","pubTime":"2022-06-17 07:27","market":"us","language":"en","title":"After-Hours Stock Movers: Adobe Falls on Lower Guidance; U.S. Steel Rises on Higher Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2244607159","media":"StreetInsider","summary":"After-Hours Stock Movers:Rhythm Pharmaceuticals 14% LOWER; Confirmed the FDA has approved the Compan","content":"<html><head></head><body><p><b>After-Hours Stock Movers:</b></p><p><a href=\"https://laohu8.com/S/RYTM\">Rhythm Pharmaceuticals</a> 14% LOWER; Confirmed the FDA has approved the Company’s supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide), a melanocortin-4 receptor (MC4R) agonist, for patients with Bardet-Biedl syndrome (BBS). Also, the FDA issued a complete response letter for the sNDA for setmelanotide in Alström syndrome.</p><p><a href=\"https://laohu8.com/S/CO\">Global Cord Blood Corporation</a> 11% HIGHER; announce that Cellenkos, Inc. recently announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application to initiate a Phase 1b, open-label study of CK0804 as an add on therapy to ruxolitinib in patients with myelofibrosis who experience a suboptimal response to ruxolitinib.</p><p><a href=\"https://laohu8.com/S/X\">United States Steel Corporation</a> 6% HIGHER; adjusted EBITDA expected to be approximately $1.6 billion, representing a new all-time best Q2 performance. Adjusted EPS is expected to range from $3.83 to $3.88, versus the consensus of $3.20.</p><p><a href=\"https://laohu8.com/S/ADBE\">Adobe Systems</a> 4% LOWER; reported Q2 EPS of $3.35, $0.04 better than the analyst estimate of $3.31. Revenue for the quarter came in at $4.39 billion versus the consensus estimate of $4.34 billion. Adobe Systems sees Q3 2022 EPS of $3.33, versus the consensus of $3.40. Adobe Systems sees Q3 2022 revenue of $4.43 billion, versus the consensus of $4.51 billion. Adobe Systems sees FY2022 EPS of $13.50, versus the consensus of $13.66. Adobe Systems sees FY2022 revenue of $17.65 billion, versus the consensus of $17.85 billion</p><p><a href=\"https://laohu8.com/S/LVTX\">LAVA Therapeutics N.V.</a> 3% HIGHER; hosted a clinical update call focused on encouraging initial Phase 1/2a clinical data for LAVA-051 in patients with chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) patients following poster presentations at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting held June 3-7, 2022, and the European Hematology Association (EHA) 2022 Congress, held June 9-12, 2022.</p><p><a href=\"https://laohu8.com/S/TRGP\">Targa Resources Corp</a>. 3% HIGHER; Agreed to acquire Lucid Energy Delaware, LLC from Riverstone Holdings LLC and Goldman Sachs Asset Management for $3.55 billion in cash.</p><p><a href=\"https://laohu8.com/S/BHC\">Bausch Health Companies Inc</a>. (NYSE: BHC) 2% HIGHER; Suspending IPO of Solta Medical.</p><p><a href=\"https://laohu8.com/S/OAS\">Oasis Petroleum</a> Inc. (NASDAQ: OAS) 1% HIGHER; announced today that its Board of Directors has, subject to certain conditions, declared a special dividend of $15.00 per share of Oasis common stock in connection with the Whiting Petroleum merger.</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Adobe Falls on Lower Guidance; U.S. Steel Rises on Higher Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Adobe Falls on Lower Guidance; U.S. Steel Rises on Higher Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-06-17 07:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=20225684><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Rhythm Pharmaceuticals 14% LOWER; Confirmed the FDA has approved the Company’s supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide), a melanocortin-4 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=20225684\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4520":"美国基建股","RYTM":"Rhythm Pharmaceuticals Inc.","BK4567":"ESG概念","BK4534":"瑞士信贷持仓","BK4527":"明星科技股","X":"美国钢铁","BK4566":"资本集团","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4554":"元宇宙及AR概念","BK4528":"SaaS概念","BK4516":"特朗普概念","BK4023":"应用软件","ADBE":"Adobe"},"source_url":"https://www.streetinsider.com/dr/news.php?id=20225684","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2244607159","content_text":"After-Hours Stock Movers:Rhythm Pharmaceuticals 14% LOWER; Confirmed the FDA has approved the Company’s supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide), a melanocortin-4 receptor (MC4R) agonist, for patients with Bardet-Biedl syndrome (BBS). Also, the FDA issued a complete response letter for the sNDA for setmelanotide in Alström syndrome.Global Cord Blood Corporation 11% HIGHER; announce that Cellenkos, Inc. recently announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application to initiate a Phase 1b, open-label study of CK0804 as an add on therapy to ruxolitinib in patients with myelofibrosis who experience a suboptimal response to ruxolitinib.United States Steel Corporation 6% HIGHER; adjusted EBITDA expected to be approximately $1.6 billion, representing a new all-time best Q2 performance. Adjusted EPS is expected to range from $3.83 to $3.88, versus the consensus of $3.20.Adobe Systems 4% LOWER; reported Q2 EPS of $3.35, $0.04 better than the analyst estimate of $3.31. Revenue for the quarter came in at $4.39 billion versus the consensus estimate of $4.34 billion. Adobe Systems sees Q3 2022 EPS of $3.33, versus the consensus of $3.40. Adobe Systems sees Q3 2022 revenue of $4.43 billion, versus the consensus of $4.51 billion. Adobe Systems sees FY2022 EPS of $13.50, versus the consensus of $13.66. Adobe Systems sees FY2022 revenue of $17.65 billion, versus the consensus of $17.85 billionLAVA Therapeutics N.V. 3% HIGHER; hosted a clinical update call focused on encouraging initial Phase 1/2a clinical data for LAVA-051 in patients with chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) patients following poster presentations at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting held June 3-7, 2022, and the European Hematology Association (EHA) 2022 Congress, held June 9-12, 2022.Targa Resources Corp. 3% HIGHER; Agreed to acquire Lucid Energy Delaware, LLC from Riverstone Holdings LLC and Goldman Sachs Asset Management for $3.55 billion in cash.Bausch Health Companies Inc. (NYSE: BHC) 2% HIGHER; Suspending IPO of Solta Medical.Oasis Petroleum Inc. (NASDAQ: OAS) 1% HIGHER; announced today that its Board of Directors has, subject to certain conditions, declared a special dividend of $15.00 per share of Oasis common stock in connection with the Whiting Petroleum merger.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9054774294,"gmtCreate":1655430954818,"gmtModify":1676535638527,"author":{"id":"3548734971517314","authorId":"3548734971517314","name":"Mkoh","avatar":"https://static.tigerbbs.com/c6226aeb6486c19c00455145eb533f98","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3548734971517314","authorIdStr":"3548734971517314"},"htmlText":"Horrific plunge","listText":"Horrific plunge","text":"Horrific plunge","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9054774294","repostId":2244607159,"repostType":4,"repost":{"id":"2244607159","pubTimestamp":1655422063,"share":"https://ttm.financial/m/news/2244607159?lang=&edition=fundamental","pubTime":"2022-06-17 07:27","market":"us","language":"en","title":"After-Hours Stock Movers: Adobe Falls on Lower Guidance; U.S. Steel Rises on Higher Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2244607159","media":"StreetInsider","summary":"After-Hours Stock Movers:Rhythm Pharmaceuticals 14% LOWER; Confirmed the FDA has approved the Compan","content":"<html><head></head><body><p><b>After-Hours Stock Movers:</b></p><p><a href=\"https://laohu8.com/S/RYTM\">Rhythm Pharmaceuticals</a> 14% LOWER; Confirmed the FDA has approved the Company’s supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide), a melanocortin-4 receptor (MC4R) agonist, for patients with Bardet-Biedl syndrome (BBS). Also, the FDA issued a complete response letter for the sNDA for setmelanotide in Alström syndrome.</p><p><a href=\"https://laohu8.com/S/CO\">Global Cord Blood Corporation</a> 11% HIGHER; announce that Cellenkos, Inc. recently announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application to initiate a Phase 1b, open-label study of CK0804 as an add on therapy to ruxolitinib in patients with myelofibrosis who experience a suboptimal response to ruxolitinib.</p><p><a href=\"https://laohu8.com/S/X\">United States Steel Corporation</a> 6% HIGHER; adjusted EBITDA expected to be approximately $1.6 billion, representing a new all-time best Q2 performance. Adjusted EPS is expected to range from $3.83 to $3.88, versus the consensus of $3.20.</p><p><a href=\"https://laohu8.com/S/ADBE\">Adobe Systems</a> 4% LOWER; reported Q2 EPS of $3.35, $0.04 better than the analyst estimate of $3.31. Revenue for the quarter came in at $4.39 billion versus the consensus estimate of $4.34 billion. Adobe Systems sees Q3 2022 EPS of $3.33, versus the consensus of $3.40. Adobe Systems sees Q3 2022 revenue of $4.43 billion, versus the consensus of $4.51 billion. Adobe Systems sees FY2022 EPS of $13.50, versus the consensus of $13.66. Adobe Systems sees FY2022 revenue of $17.65 billion, versus the consensus of $17.85 billion</p><p><a href=\"https://laohu8.com/S/LVTX\">LAVA Therapeutics N.V.</a> 3% HIGHER; hosted a clinical update call focused on encouraging initial Phase 1/2a clinical data for LAVA-051 in patients with chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) patients following poster presentations at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting held June 3-7, 2022, and the European Hematology Association (EHA) 2022 Congress, held June 9-12, 2022.</p><p><a href=\"https://laohu8.com/S/TRGP\">Targa Resources Corp</a>. 3% HIGHER; Agreed to acquire Lucid Energy Delaware, LLC from Riverstone Holdings LLC and Goldman Sachs Asset Management for $3.55 billion in cash.</p><p><a href=\"https://laohu8.com/S/BHC\">Bausch Health Companies Inc</a>. (NYSE: BHC) 2% HIGHER; Suspending IPO of Solta Medical.</p><p><a href=\"https://laohu8.com/S/OAS\">Oasis Petroleum</a> Inc. (NASDAQ: OAS) 1% HIGHER; announced today that its Board of Directors has, subject to certain conditions, declared a special dividend of $15.00 per share of Oasis common stock in connection with the Whiting Petroleum merger.</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Adobe Falls on Lower Guidance; U.S. Steel Rises on Higher Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Adobe Falls on Lower Guidance; U.S. Steel Rises on Higher Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-06-17 07:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=20225684><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Rhythm Pharmaceuticals 14% LOWER; Confirmed the FDA has approved the Company’s supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide), a melanocortin-4 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=20225684\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4520":"美国基建股","RYTM":"Rhythm Pharmaceuticals Inc.","BK4567":"ESG概念","BK4534":"瑞士信贷持仓","BK4527":"明星科技股","X":"美国钢铁","BK4566":"资本集团","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4554":"元宇宙及AR概念","BK4528":"SaaS概念","BK4516":"特朗普概念","BK4023":"应用软件","ADBE":"Adobe"},"source_url":"https://www.streetinsider.com/dr/news.php?id=20225684","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2244607159","content_text":"After-Hours Stock Movers:Rhythm Pharmaceuticals 14% LOWER; Confirmed the FDA has approved the Company’s supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide), a melanocortin-4 receptor (MC4R) agonist, for patients with Bardet-Biedl syndrome (BBS). Also, the FDA issued a complete response letter for the sNDA for setmelanotide in Alström syndrome.Global Cord Blood Corporation 11% HIGHER; announce that Cellenkos, Inc. recently announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application to initiate a Phase 1b, open-label study of CK0804 as an add on therapy to ruxolitinib in patients with myelofibrosis who experience a suboptimal response to ruxolitinib.United States Steel Corporation 6% HIGHER; adjusted EBITDA expected to be approximately $1.6 billion, representing a new all-time best Q2 performance. Adjusted EPS is expected to range from $3.83 to $3.88, versus the consensus of $3.20.Adobe Systems 4% LOWER; reported Q2 EPS of $3.35, $0.04 better than the analyst estimate of $3.31. Revenue for the quarter came in at $4.39 billion versus the consensus estimate of $4.34 billion. Adobe Systems sees Q3 2022 EPS of $3.33, versus the consensus of $3.40. Adobe Systems sees Q3 2022 revenue of $4.43 billion, versus the consensus of $4.51 billion. Adobe Systems sees FY2022 EPS of $13.50, versus the consensus of $13.66. Adobe Systems sees FY2022 revenue of $17.65 billion, versus the consensus of $17.85 billionLAVA Therapeutics N.V. 3% HIGHER; hosted a clinical update call focused on encouraging initial Phase 1/2a clinical data for LAVA-051 in patients with chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) patients following poster presentations at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting held June 3-7, 2022, and the European Hematology Association (EHA) 2022 Congress, held June 9-12, 2022.Targa Resources Corp. 3% HIGHER; Agreed to acquire Lucid Energy Delaware, LLC from Riverstone Holdings LLC and Goldman Sachs Asset Management for $3.55 billion in cash.Bausch Health Companies Inc. (NYSE: BHC) 2% HIGHER; Suspending IPO of Solta Medical.Oasis Petroleum Inc. (NASDAQ: OAS) 1% HIGHER; announced today that its Board of Directors has, subject to certain conditions, declared a special dividend of $15.00 per share of Oasis common stock in connection with the Whiting Petroleum merger.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9054775946,"gmtCreate":1655430856985,"gmtModify":1676535638488,"author":{"id":"3559395309338899","authorId":"3559395309338899","name":"Jenyii","avatar":"https://static.tigerbbs.com/529eb98195626d2d61bbc27ff77d02c9","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3559395309338899","authorIdStr":"3559395309338899"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9054775946","repostId":2244607159,"repostType":4,"repost":{"id":"2244607159","pubTimestamp":1655422063,"share":"https://ttm.financial/m/news/2244607159?lang=&edition=fundamental","pubTime":"2022-06-17 07:27","market":"us","language":"en","title":"After-Hours Stock Movers: Adobe Falls on Lower Guidance; U.S. Steel Rises on Higher Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2244607159","media":"StreetInsider","summary":"After-Hours Stock Movers:Rhythm Pharmaceuticals 14% LOWER; Confirmed the FDA has approved the Compan","content":"<html><head></head><body><p><b>After-Hours Stock Movers:</b></p><p><a href=\"https://laohu8.com/S/RYTM\">Rhythm Pharmaceuticals</a> 14% LOWER; Confirmed the FDA has approved the Company’s supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide), a melanocortin-4 receptor (MC4R) agonist, for patients with Bardet-Biedl syndrome (BBS). Also, the FDA issued a complete response letter for the sNDA for setmelanotide in Alström syndrome.</p><p><a href=\"https://laohu8.com/S/CO\">Global Cord Blood Corporation</a> 11% HIGHER; announce that Cellenkos, Inc. recently announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application to initiate a Phase 1b, open-label study of CK0804 as an add on therapy to ruxolitinib in patients with myelofibrosis who experience a suboptimal response to ruxolitinib.</p><p><a href=\"https://laohu8.com/S/X\">United States Steel Corporation</a> 6% HIGHER; adjusted EBITDA expected to be approximately $1.6 billion, representing a new all-time best Q2 performance. Adjusted EPS is expected to range from $3.83 to $3.88, versus the consensus of $3.20.</p><p><a href=\"https://laohu8.com/S/ADBE\">Adobe Systems</a> 4% LOWER; reported Q2 EPS of $3.35, $0.04 better than the analyst estimate of $3.31. Revenue for the quarter came in at $4.39 billion versus the consensus estimate of $4.34 billion. Adobe Systems sees Q3 2022 EPS of $3.33, versus the consensus of $3.40. Adobe Systems sees Q3 2022 revenue of $4.43 billion, versus the consensus of $4.51 billion. Adobe Systems sees FY2022 EPS of $13.50, versus the consensus of $13.66. Adobe Systems sees FY2022 revenue of $17.65 billion, versus the consensus of $17.85 billion</p><p><a href=\"https://laohu8.com/S/LVTX\">LAVA Therapeutics N.V.</a> 3% HIGHER; hosted a clinical update call focused on encouraging initial Phase 1/2a clinical data for LAVA-051 in patients with chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) patients following poster presentations at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting held June 3-7, 2022, and the European Hematology Association (EHA) 2022 Congress, held June 9-12, 2022.</p><p><a href=\"https://laohu8.com/S/TRGP\">Targa Resources Corp</a>. 3% HIGHER; Agreed to acquire Lucid Energy Delaware, LLC from Riverstone Holdings LLC and Goldman Sachs Asset Management for $3.55 billion in cash.</p><p><a href=\"https://laohu8.com/S/BHC\">Bausch Health Companies Inc</a>. (NYSE: BHC) 2% HIGHER; Suspending IPO of Solta Medical.</p><p><a href=\"https://laohu8.com/S/OAS\">Oasis Petroleum</a> Inc. (NASDAQ: OAS) 1% HIGHER; announced today that its Board of Directors has, subject to certain conditions, declared a special dividend of $15.00 per share of Oasis common stock in connection with the Whiting Petroleum merger.</p></body></html>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Adobe Falls on Lower Guidance; U.S. Steel Rises on Higher Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Adobe Falls on Lower Guidance; U.S. Steel Rises on Higher Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-06-17 07:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=20225684><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:Rhythm Pharmaceuticals 14% LOWER; Confirmed the FDA has approved the Company’s supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide), a melanocortin-4 ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=20225684\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4520":"美国基建股","RYTM":"Rhythm Pharmaceuticals Inc.","BK4567":"ESG概念","BK4534":"瑞士信贷持仓","BK4527":"明星科技股","X":"美国钢铁","BK4566":"资本集团","BK4581":"高盛持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4554":"元宇宙及AR概念","BK4528":"SaaS概念","BK4516":"特朗普概念","BK4023":"应用软件","ADBE":"Adobe"},"source_url":"https://www.streetinsider.com/dr/news.php?id=20225684","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2244607159","content_text":"After-Hours Stock Movers:Rhythm Pharmaceuticals 14% LOWER; Confirmed the FDA has approved the Company’s supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide), a melanocortin-4 receptor (MC4R) agonist, for patients with Bardet-Biedl syndrome (BBS). Also, the FDA issued a complete response letter for the sNDA for setmelanotide in Alström syndrome.Global Cord Blood Corporation 11% HIGHER; announce that Cellenkos, Inc. recently announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application to initiate a Phase 1b, open-label study of CK0804 as an add on therapy to ruxolitinib in patients with myelofibrosis who experience a suboptimal response to ruxolitinib.United States Steel Corporation 6% HIGHER; adjusted EBITDA expected to be approximately $1.6 billion, representing a new all-time best Q2 performance. Adjusted EPS is expected to range from $3.83 to $3.88, versus the consensus of $3.20.Adobe Systems 4% LOWER; reported Q2 EPS of $3.35, $0.04 better than the analyst estimate of $3.31. Revenue for the quarter came in at $4.39 billion versus the consensus estimate of $4.34 billion. Adobe Systems sees Q3 2022 EPS of $3.33, versus the consensus of $3.40. Adobe Systems sees Q3 2022 revenue of $4.43 billion, versus the consensus of $4.51 billion. Adobe Systems sees FY2022 EPS of $13.50, versus the consensus of $13.66. Adobe Systems sees FY2022 revenue of $17.65 billion, versus the consensus of $17.85 billionLAVA Therapeutics N.V. 3% HIGHER; hosted a clinical update call focused on encouraging initial Phase 1/2a clinical data for LAVA-051 in patients with chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) patients following poster presentations at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting held June 3-7, 2022, and the European Hematology Association (EHA) 2022 Congress, held June 9-12, 2022.Targa Resources Corp. 3% HIGHER; Agreed to acquire Lucid Energy Delaware, LLC from Riverstone Holdings LLC and Goldman Sachs Asset Management for $3.55 billion in cash.Bausch Health Companies Inc. (NYSE: BHC) 2% HIGHER; Suspending IPO of Solta Medical.Oasis Petroleum Inc. (NASDAQ: OAS) 1% HIGHER; announced today that its Board of Directors has, subject to certain conditions, declared a special dividend of $15.00 per share of Oasis common stock in connection with the Whiting Petroleum merger.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":671,"commentSize":271,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2244607159"}